These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2179418)

  • 1. Cyclophilin content of normal and psoriatic epidermis.
    Griffiths CE; Fisher GJ; Harding MW; Elder JT; Voorhees JJ
    J Invest Dermatol; 1990 Apr; 94(4):436-40. PubMed ID: 2179418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GRO-alpha mRNA is selectively overexpressed in psoriatic epidermis and is reduced by cyclosporin A in vivo, but not in cultured keratinocytes.
    Kojima T; Cromie MA; Fisher GJ; Voorhees JJ; Elder JT
    J Invest Dermatol; 1993 Dec; 101(6):767-72. PubMed ID: 8245503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The helix-loop-helix transcription factor Id1 is highly expressed in psoriatic involved skin.
    Björntorp E; Parsa R; Thornemo M; Wennberg AM; Lindahl A
    Acta Derm Venereol; 2003; 83(6):403-9. PubMed ID: 14690332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protooncogene expression in normal and psoriatic skin.
    Elder JT; Tavakkol A; Klein SB; Zeigler ME; Wicha M; Voorhees JJ
    J Invest Dermatol; 1990 Jan; 94(1):19-25. PubMed ID: 1688596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ expression of messenger RNA of interleukin-1 and interleukin-6 in psoriasis: interleukin-6 involved in formation of psoriatic lesions.
    Ohta Y; Katayama I; Funato T; Yokozeki H; Nishiyama S; Hirano T; Kishimoto T; Nishioka K
    Arch Dermatol Res; 1991; 283(6):351-6. PubMed ID: 1796815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased phospholipase C-catalyzed hydrolysis of phosphatidylinositol-4,5-bisphosphate and 1,2-sn-diacylglycerol content in psoriatic involved compared to uninvolved and normal epidermis.
    Fisher GJ; Talwar HS; Baldassare JJ; Henderson PA; Voorhees JJ
    J Invest Dermatol; 1990 Oct; 95(4):428-35. PubMed ID: 2170539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes.
    Grossman RM; Krueger J; Yourish D; Granelli-Piperno A; Murphy DP; May LT; Kupper TS; Sehgal PB; Gottlieb AB
    Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6367-71. PubMed ID: 2474833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased DNA synthesis of uninvolved psoriatic epidermis is maintained in vitro.
    Kragballe K; Desjarlais L; Marcelo CL
    Br J Dermatol; 1985 Mar; 112(3):263-70. PubMed ID: 2579668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Programmed death-ligand 1, 2 expressions are decreased in the psoriatic epidermis.
    Kim DS; Je JH; Kim SH; Shin D; Kim TG; Kim DY; Kim SM; Lee MG
    Arch Dermatol Res; 2015 Aug; 307(6):531-8. PubMed ID: 26133691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of calcineurin/NFAT in human skin and psoriasis and inhibition of calcineurin/NFAT activation in human keratinocytes by cyclosporin A.
    Al-Daraji WI; Grant KR; Ryan K; Saxton A; Reynolds NJ
    J Invest Dermatol; 2002 May; 118(5):779-88. PubMed ID: 11982754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning and expression of a novel keratinocyte protein (psoriasis-associated fatty acid-binding protein [PA-FABP]) that is highly up-regulated in psoriatic skin and that shares similarity to fatty acid-binding proteins.
    Madsen P; Rasmussen HH; Leffers H; Honoré B; Celis JE
    J Invest Dermatol; 1992 Sep; 99(3):299-305. PubMed ID: 1512466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell activation is potentiated by cytokines released by lesional psoriatic, but not normal, epidermis.
    Chang EY; Hammerberg C; Fisher G; Baadsgaard O; Ellis CN; Voorhees JJ; Cooper KD
    Arch Dermatol; 1992 Nov; 128(11):1479-85. PubMed ID: 1359841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of protein kinase C isoenzymes in normal and psoriatic adult human skin: reduced expression of protein kinase C-beta II in psoriasis.
    Fisher GJ; Tavakkol A; Leach K; Burns D; Basta P; Loomis C; Griffiths CE; Cooper KD; Reynolds NJ; Elder JT
    J Invest Dermatol; 1993 Oct; 101(4):553-9. PubMed ID: 8409523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of a human endogenous retrovirus E transmembrane envelope glycoprotein in normal, psoriatic and atopic dermatitis human skin.
    Bessis D; Molès JP; Basset-Séguin N; Tesniere A; Arpin C; Guilhou JJ
    Br J Dermatol; 2004 Oct; 151(4):737-45. PubMed ID: 15491412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporin A rapidly inhibits epidermal cytokine expression in psoriasis lesions, but not in cytokine-stimulated cultured keratinocytes.
    Elder JT; Hammerberg C; Cooper KD; Kojima T; Nair RP; Ellis CN; Voorhees JJ
    J Invest Dermatol; 1993 Dec; 101(6):761-6. PubMed ID: 8245502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
    Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
    Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basement membrane alterations in psoriasis are accompanied by epidermal overexpression of MMP-2 and its inhibitor TIMP-2.
    Fleischmajer R; Kuroda K; Hazan R; Gordon RE; Lebwohl MG; Sapadin AN; Unda F; Iehara N; Yamada Y
    J Invest Dermatol; 2000 Nov; 115(5):771-7. PubMed ID: 11069613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1 receptor antagonist in normal and psoriatic epidermis.
    Hammerberg C; Arend WP; Fisher GJ; Chan LS; Berger AE; Haskill JS; Voorhees JJ; Cooper KD
    J Clin Invest; 1992 Aug; 90(2):571-83. PubMed ID: 1386612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin-derived antileukoproteinase (SKALP) and epidermal fatty acid-binding protein (E-FABP): two novel markers of the psoriatic phenotype that respond differentially to topical steroid.
    Kuijpers AL; Bergers M; Siegenthaler G; Zeeuwen PL; van de Kerkhof PC; Schalkwijk J
    Acta Derm Venereol; 1997 Jan; 77(1):14-9. PubMed ID: 9059669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical localization of SKALP/elafin in psoriatic epidermis.
    Schalkwijk J; van Vlijmen IM; Alkemade JA; de Jongh GJ
    J Invest Dermatol; 1993 Apr; 100(4):390-3. PubMed ID: 8454901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.